First Mercantile Trust’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-2,538
| Closed | -$474K | – | 880 |
|
|
2021
Q1 | $474K | Sell |
2,538
-3,216
| -56% | -$629K | 0.05% | 192 |
|
|
2020
Q4 | $971K | Buy |
5,754
+1,959
| +52% | +$292K | 0.11% | 104 |
|
|
2020
Q3 | $540K | Buy |
3,795
+1,487
| +64% | +$230K | 0.07% | 164 |
|
|
2020
Q2 | $379K | Sell |
2,308
-970
| -30% | -$149K | 0.05% | 229 |
|
|
2020
Q1 | $455K | Sell |
3,278
-520
| -14% | -$71.4K | 0.07% | 169 |
|
|
2019
Q4 | $499K | Sell |
3,798
-370
| -9% | -$42.9K | 0.06% | 223 |
|
|
2019
Q3 | $466K | Buy |
4,168
+600
| +17% | +$66.8K | 0.05% | 255 |
|
|
2019
Q2 | $395K | Hold |
3,568
| – | – | 0.04% | 258 |
|
|
2019
Q1 | $463K | Sell |
3,568
-1,132
| -24% | -$138K | 0.11% | 225 |
|
|
2018
Q4 | $544K | Sell |
4,700
-1,200
| -20% | -$134K | 0.13% | 182 |
|
|
2018
Q3 | $633K | Sell |
5,900
-1,400
| -19% | -$140K | 0.12% | 193 |
|
|
2018
Q2 | $623K | Buy |
+7,300
| New | +$600K | 0.12% | 195 |
|
|
2018
Q1 | – | Sell |
-15,490
| Closed | -$1.31M | – | 800 |
|
|
2017
Q4 | $1.31M | Sell |
15,490
-2,260
| -13% | -$192K | 0.26% | 83 |
|
|
2017
Q3 | $1.52M | Sell |
17,750
-950
| -5% | -$77.9K | 0.27% | 76 |
|
|
2017
Q2 | $1.54M | Sell |
18,700
-2,860
| -13% | -$233K | 0.28% | 73 |
|
|
2017
Q1 | $1.81M | Sell |
21,560
-1,751
| -8% | -$140K | 0.28% | 81 |
|
|
2016
Q4 | $1.72M | Buy |
+23,311
| New | +$1.74M | 0.27% | 84 |
|
|
2016
Q2 | – | Sell |
-2,278
| Closed | -$164K | – | 900 |
|
|
2016
Q1 | $164K | Sell |
2,278
-2,345
| -51% | -$177K | 0.02% | 625 |
|
|
2015
Q4 | $390K | Sell |
4,623
-330
| -7% | -$27.4K | 0.04% | 516 |
|
|
2015
Q3 | $415K | Hold |
4,953
| – | – | 0.04% | 509 |
|
|
2015
Q2 | $414K | Sell |
4,953
-1,373
| -22% | -$105K | 0.04% | 559 |
|
|
2015
Q1 | $460K | Sell |
6,326
-5,465
| -46% | -$389K | 0.04% | 523 |
|
|
2014
Q4 | $813K | Sell |
11,791
-2,070
| -15% | -$140K | 0.07% | 383 |
|
|
2014
Q3 | $899K | Sell |
13,861
-234
| -2% | -$14.8K | 0.07% | 358 |
|
|
2014
Q2 | $876K | Buy |
14,095
+3,650
| +35% | +$218K | 0.07% | 384 |
|
|
2014
Q1 | $615K | Buy |
10,445
+4,262
| +69% | +$238K | 0.04% | 539 |
|
|
2013
Q4 | $315K | Sell |
6,183
-6,508
| -51% | -$326K | 0.02% | 672 |
|
|
2013
Q3 | $639K | Buy |
12,691
+90
| +0.7% | +$4.71K | 0.05% | 504 |
|
|
2013
Q2 | $619K | Buy |
+12,601
| New | +$686K | 0.05% | 484 |
|
Other funds holding LLY
First Mercantile Trust's LLY Position: Q2 2021 in Review
First Mercantile Trust sold out of Eli Lilly (LLY) in Q2 2021, closing a stake of 2,538 shares — an estimated $474K sold.
First Mercantile Trust first reported a position in LLY in Q2 2013 and held it in 29 quarters. The position peaked at $1.81M in Q1 2017. 2,021 funds tracked by Wall St. Rank hold LLY as of Q2 2021.
- First Mercantile Trust reported no remaining Eli Lilly position as of Q2 2021 after selling out during the quarter.
- First Mercantile Trust sold 2,538 Eli Lilly shares in Q2 2021, an estimated $474K.
- First Mercantile Trust first reported a position in Eli Lilly in Q2 2013 and held it in 29 quarters.
- First Mercantile Trust's Eli Lilly position peaked at $1.81M in Q1 2017.
- 2,021 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2021.
Based on First Mercantile Trust's 13F filing for Q2 2021, filed 10 Aug 2021.